Clinical Trial Update: Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization

View source ↗

Summary

Clinical trial update analyzing myoma microvascularization with the ultrasound contrast agent SonoVue before and after uterine artery embolization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• SonoVue (sulfur hexafluoride microbubbles)

Snippet

Sponsor: University Hospital, Tours | Conditions: Myoma | Status: UNKNOWN